URTI
10
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study
LC-Plasma for Preventing URTIs and Reducing Symptoms
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
Perioperative Outcomes for Children With Preoperative URTI Symptoms After COVID-19 Pandemic
The Effects of Bio Gelee Royale Forte on Immune Health in Healthy Adults
PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays
Xylitol for the Prevention of Acute Otitis Media Episodes in Children
Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data
Innate Immune Response to (An)Aerobic Exercise in Rowing Athletes
Translating Clinicians' Beliefs Into Implementation Interventions (TRACII)